Clinical trial · Interventional
Exercise During Chemotherapy for Patients With Hematological Malignancies
NCT00884364CI-TRIAL-00002926unknownPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The trial will evaluate the effects of aerobic exercise in patients undergoing chemotherapy for the treatment of a hematological neoplastic disease.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematological Diseases | — | UNRESOLVED | — |
| Hematological Malignancies | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Aerobic exercise | Other | — | UNRESOLVED |
| Fatigue counseling | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Control
- interventionNames
- Behavioral: Fatigue counseling
- type
- EXPERIMENTAL
- label
- Exercise
- interventionNames
- Other: Aerobic exercise
Primary outcomes (1)
- measure
- Fatigue
- timeFrame
- At recruitment and after 12 weeks
Secondary outcomes (2)
- measure
- Complications
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Hematological malignant disease * Current chemotherapy * Understanding of written German Exclusion Criteria: * Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise * Pathological stress-ECG at recruitment
References
Publications (0)
Data not yet available
No reference posted for this study.